...
首页> 外文期刊>Investigative ophthalmology & visual science >High prevalence of mutations in the EYS gene in japanese patients with autosomal recessive retinitis pigmentosa
【24h】

High prevalence of mutations in the EYS gene in japanese patients with autosomal recessive retinitis pigmentosa

机译:日本常染色体隐性遗传性视网膜色素变性患者的EYS基因突变高发生率

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE. To screen for disease-causing mutations in the Eyes shut homolog (EYS) gene in Japanese patients with retinitis pigmentosa (RP). METHODS. Blood samples were obtained from 68 RP patients and 68 controls. Genomic DNA was extracted from the blood samples and used for screening of mutations in the coding exons by direct sequencing. Each patient underwent a detailed clinical examination. RESULTS. Nine nucleotide sequence variations causing amino acid changes were observed in homozygous or heterozygous alleles in 26 patients but not in 68 controls. Seven truncating mutations were found in 21 (32.8%) of 64 patients with nonsyndromic RP composed of 23 autosomal recessive RP (arRP) and 41 sporadic cases. The most abundant mutation was p.S1653Kfs*2, which was generated by a single adenine insertion into exon 26 (c.4957dupA) and was carried by 15 patients. The mutation p.Y2935*, produced by a single nucleotide substitution (c.8805C>A) in the last exon, was carried by five patients. These two truncating mutations were probably founder mutations because each was carried by the particular haplotype. The patients with homozygous or compound heterozygous truncating mutations showed a severe decline in visual acuity, whereas those with a single truncating mutation showed a mild decline. CONCLUSIONS. One-third of Japanese patients with nonsyndromic arRP carried probable pathogenic mutations in the EYS gene, including two founder mutations. Because the genotype was correlated with the phenotype, genotyping in the EYS gene could be a valuable tool for predicting long-term prognoses of Japanese patients with arRP and thus could be useful for genetic counseling and future gene therapy.
机译:目的。为了筛查日本色素性视网膜炎(RP)患者的眼中致病突变,请关闭同源基因(EYS)。方法。从68名RP患者和68名对照获得血液样品。从血样中提取基因组DNA,并通过直接测序将其用于编码外显子中的突变筛选。每位患者均接受了详细的临床检查。结果。在26名患者的纯合或杂合等位基因中观察到了导致氨基酸变化的九个核苷酸序列变异,但在68名对照中未观察到。在64例非综合征性RP患者中,有21例(32.8%)发现了七个截短突变,其中23例为常染色体隐性RP(arRP),而41例为散发性病例。最丰富的突变是p.S1653Kfs * 2,它是由单个腺嘌呤插入外显子26(c.4957dupA)产生的,由15位患者携带。由最后一个外显子中的单个核苷酸取代(c.8805C> A)产生的突变p.Y2935 *由五名患者携带。这两个截短突变很可能是创始人突变,因为每个突变都是由特定的单倍型携带的。具有纯合子或复合杂合性截断突变的患者显示视力严重下降,而具有单个截断突变的患者显示轻度下降。结论。日本有非综合征性arRP的日本患者中有三分之一在EYS基因中携带可能的致病突变,包括两个创始人突变。因为基因型与表型相关,所以EYS基因的基因分型可能是预测日本arRP患者长期预后的有价值的工具,因此可用于遗传咨询和未来的基因治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号